HOXC6 Overexpression Is Associated With Ki-67 Expression and Poor Survival in NPC Patients
Shih‐Lun Chang, Ti‐Chun Chan, Tzu‐Ju Chen, Sung‐Wei Lee, Li‐Ching Lin, Khin Than Win · Journal of Cancer · 2017
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2017
Abstract
BACKGROUND: Homeobox (HOX) genes are expressed in adult cells and regulate expression of genes involved in cell proliferation as well as cell-cell and cell-extracellular matrix interactions.Dysregulation of HOX gene expression plays important roles in carcinogenesis in a variety of organs.Through data mining on a published transcriptome dataset, this study first identified Homeobox protein Hox-C6 (HOXC6) gene as one of the differentially upregulated genes in nasopharyngeal carcinoma (NPC).We aimed to evaluate HOXC6 expression and its prognostic effect in a large cohort of NPC patients.METHODS: We retrospectively examined the HOXC6 expression and Ki-67 index by immunohistochemistry in biopsy specimens from 124 patients with non-metastasized NPC.The results were correlated with the clinicopathological variables including disease-specific survival (DSS), metastasis-free survival (MeFS), and local recurrence-free survival (LRFS).RESULTS: HOXC6 high expression was positively correlated with increased Ki-67 labeling index, and significantly associated with increment of tumor stage (p=0.024),advanced nodal status (p<0.001) and American Joint Committee on Cancer (AJCC) stage (p=0.002).Its expression also correlated with worse prognosis in terms of DSS (p=0.008),MeFS (p=0.0047)univariately.In multivariate analyses, HOXC6 expression still remained prognostically independent to portend worse DSS (p=0.015,hazard ratio=1.988)and MeFS (p=0.036,hazard ratio=1.899),together with stage III-IV (p=0.024,DSS; p=0.043,MeFS).CONCLUSION: In summary, our results suggest HOXC6 may play a critical role in NPC progression and may serve as a potential prognostic biomarker in NPC patients.
Open the resolved locator · 10.7150/jca.18893
Metadata licence: OpenAlex metadata (CC0)